-
Rasmussen Hsu posted an update 6 months, 3 weeks ago
Background Despite its cardiotoxicity doxorubicin is widely used for the treatment of paediatric malignancies. Current treatment regimens appear to be suboptimal as treatment strategies vary and do not follow a clear pharmacological rationale. Standardisation of dosing strategies in particular for infants and younger children is required but is…[Read more]
-
Rasmussen Hsu became a registered member 7 months ago
Skip to content
